A Phase 1-2 Study of Weekly OGX-011 Plus a Gemcitabine/Platinum-Based Regimen in Patients With Stage IIIB or IV Non Small Cell Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Custirsen (Primary) ; Carboplatin; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors OncoGenex Technologies
- 31 Aug 2018 Biomarkers information updated
- 10 Jul 2012 Results from the phase II portion of this trial have been reported in an OncoGenex Pharmaceuticals media release.
- 04 Jan 2012 Results published in an early online version of the Journal of Thoracic Oncology, according to an OncoGenex Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History